Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Rakovina Therapeutics Inc. announced its participation in the 13th Annual Tumour Models London Summit, where it will showcase its innovative cancer treatment research. Prof. Mads Daugaard, the company’s president, will present the development of 3D bioprinted bone mimics for drug screening and cancer research. The summit is a platform for sharing advanced insights into drug discovery and cancer therapy.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
